Skip to main content
Figure 4 | Journal of Experimental & Clinical Cancer Research

Figure 4

From: Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia

Figure 4

BGS analysis depicts EBF3 promoter hypermethylation in AML samples. Eight NBM samples and eight AML samples were selected for further analysis by BGS. The EBF3 promoter was methylated in the AML samples (67.0% - 77.0%); whereas the EBF3 promoter was methylated in only 41.0% - 50.0% in the NBM samples. ● methylated cytosines; ○ unmethylated cytosines.

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us